PRESS RELEASE published on 02/08/2024 at 22:05, 2 years 8 months ago Applied DNA Announces First Quarter Fiscal Year 2024 Financial Results Applied DNA Sciences, Inc. (NASDAQ:APDN) announces Q1 fiscal year 2024 financial results and progress on GMP production capacity for mRNA therapeutics. Projects initial facility capacity to enable up to $15 million Linea IVT revenue annually Financial Results Applied DNA Sciences MRNA Therapeutics GMP Production Capacity Linea IVT Revenue
PRESS RELEASE published on 02/05/2024 at 19:00, 2 years 8 months ago Applied DNA to Report First Quarter Fiscal 2024 Financial Results on Thursday, February 8, 2024 Applied DNA Sciences, Inc. will release first quarter fiscal 2024 financial results after market close on February 8, 2024, with a conference call for analysts. The company operates in biotechnology developing DNA detection and production technologies Financial Results Conference Call Biotechnology Applied DNA Sciences DNA Detection
PRESS RELEASE published on 02/02/2024 at 22:15, 2 years 8 months ago Applied DNA Announces Closing of $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules Applied DNA Sciences, Inc. closes registered direct offering of common stock priced at-the-market with institutional investors. Proceeds to be used for therapeutic DNA production services Registered Direct Offering Institutional Investors Common Stock Applied DNA Sciences DNA Technologies
PRESS RELEASE published on 01/31/2024 at 14:00, 2 years 8 months ago Applied DNA Announces $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules Applied DNA Sciences, Inc. announces a registered direct offering and a concurrent private placement to certain existing institutional investors. Maxim Group LLC acts as exclusive placement agent Registered Direct Offering Applied DNA Sciences Securities Purchase Agreements Maxim Group LLC DNA Technologies
PRESS RELEASE published on 12/14/2023 at 14:00, 2 years 10 months ago Applied DNA Announces Joint Development Agreement to Integrate Linea(TM) IVT Platform into CDMO Kudo Biotechnology’s mRNA Manufacturing Workflow
PRESS RELEASE published on 12/07/2023 at 22:05, 2 years 10 months ago Applied DNA Announces Fourth Quarter Fiscal Year 2023 Financial Results
PRESS RELEASE published on 12/05/2023 at 14:30, 2 years 10 months ago Applied DNA to Report Fiscal 2023 Fourth Quarter and Year End Financial Results on December 7, 2023 Applied DNA Sciences, Inc. (NASDAQ:APDN) will release its Q4 and full year 2023 financial results on December 7, 2023, after the market close. A conference call for investors will follow to discuss the results Financial Results Conference Call Investor Relations Applied DNA Sciences NASDAQ:APDN
PRESS RELEASE published on 11/28/2023 at 14:30, 2 years 10 months ago Applied DNA Announces Receipt of Linea(TM) DNA Follow-On Order for Cancer Diagnostic Application
PRESS RELEASE published on 11/16/2023 at 14:30, 2 years 11 months ago Applied DNA Extends Application of Linea(TM) IVT Platform to saRNA (self-amplifying mRNA)
PRESS RELEASE published on 11/09/2023 at 15:15, 2 years 11 months ago Applied DNA Ships First saRNA (self-amplifying mRNA) IVT Template Generated by Linea(TM) DNA Platform
Published on 10/24/2026 at 00:04, 2 days 6 hours ago Sparta Capital Ltd. Provides Corporate Update on Reinstatement Review, Financial Statement Corrections and Governance Matters
Published on 10/23/2026 at 23:30, 2 days 6 hours ago Algo Grande Commissions Independent NI 43-101 Update to Capture First Year of Progress at Adelita
Published on 10/23/2026 at 21:55, 2 days 8 hours ago Apex Closes Offering and Completes NASDAQ Listing
Published on 10/23/2026 at 16:00, 2 days 14 hours ago Leggett Dynamics's Mid-Class Massage System Wins Gasgoo's Best Technical Practice Award
Published on 10/26/2026 at 02:05, 4 hours 18 minutes ago Tin Men Capital leads US$7.4M Series A for Vision AI startup Ailytics to expand across APAC, US and Gulf
Published on 10/24/2026 at 23:44, 1 day 6 hours ago EQS-Adhoc: HomeToGo SE: Unauthorized data exfiltration at subsidiary SECRA Bookings GmbH
Published on 10/24/2026 at 14:15, 1 day 16 hours ago Winners of the 2026 INPD Awards Announced, C-Beauty Takes Home Multiple Prestigious Honors
Published on 10/24/2026 at 06:30, 1 day 23 hours ago AI and EV Boom Draws $690 Million in Advanced Materials Investment Plans to Thailand
Published on 10/23/2026 at 18:55, 2 days 11 hours ago Qatar's Years of Culture Initiative Announces Partner Countries Through 2030
Published on 10/23/2026 at 20:33, 2 days 9 hours ago Disclosure of transactions in own shares from October 19 to October 23, 2026
Published on 10/23/2026 at 17:45, 2 days 12 hours ago Imerys-10-2026-information-share-capital-and-voting-rights-as-of-30-September-2026
Published on 10/22/2026 at 18:00, 3 days 12 hours ago THERMADOR GROUPE : Completion of the share buy-back programme launched in August
Published on 10/22/2026 at 18:00, 3 days 12 hours ago bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics